Skip to main content

MARCUS CORP

For the period ended Mar 31, 2026. Filed Apr 30, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed Apr 30, 2026

MCS$26.99+0.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Operations

(in thousands, except per share data)

Three Months Ended
March 31,2026March 31,2025
Revenues:
Theatre admissions$44,825$40,931
Rooms20,46219,275
Theatre concessions39,56538,000
Food and beverage17,46017,829
Other revenues21,69422,874
144,006138,909
Cost reimbursements10,3989,857
Total revenues154,404148,766
Costs and expenses:
Theatre operations50,72949,670
Rooms10,3189,906
Theatre concessions17,17017,451
Food and beverage15,05614,629
Advertising and marketing5,7355,244
Administrative25,31124,716
Depreciation and amortization17,83517,838
Rent6,1876,217
Property taxes4,2824,409
Other operating expenses10,56310,606
(Gain) loss on disposition of property, equipment and other assets81(1,365)
Reimbursed costs10,3989,857
Total costs and expenses173,665169,178
Operating loss(19,261)(20,412)
Other income (expense):
Investment income (loss)2074
Interest expense(2,630)(2,822)
Other income (expense)(447)(444)
Equity earnings (losses) from unconsolidated joint ventures(674)(570)
(3,731)(3,762)
Earnings (loss) before income taxes(22,992)(24,174)
Income tax benefit(7,639)(7,358)
Net earnings (loss)$(15,353)$(16,816)
Net earnings (loss) per share - basic:
Common Stock$(0.51)$(0.54)
Class B Common Stock$(0.46)$(0.50)
Net earnings (loss) per share - diluted:
Common Stock$(0.51)$(0.54)
Class B Common Stock$(0.46)$(0.50)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.